Note that imaging at all sites includes a non-contrast CT head to spot a hemorrhage and assess ischemic changes (25), which is critical in determining tPA eligibility, as well as a CT Angiography (CTA) of the head and neck to assess collaterals and determines their eligibility for further EVT treatment (26). The gene discussed is PLAT; the disease is hemorrhage.